Pharmaceutical company Johnson & Johnson struck a deal Tuesday to acquire Abiomed, the heart pump manufacturer. J&J will pay $16.6 billion in cash for the acquisition, valuing the stock at $380...
On Monday, September 19, McKesson announced that it had signed an agreement with Rx Savings Solutions. This agreement focuses on the company’s plans to acquire Rx Savings Solutions to advance the...
The prospective Merck & Co. acquisition of Seattle-based biotech firm Seagen would be the largest pharmaceutical acquisition since 2020 if it is completed. Initial indications that Merck was...
Sandoz, a Novartis division, recently acquired a UK-based medical and drug delivery device company, Coalesce Product Development Limited.
Through the terms of the agreement, Sandoz...
Thermo Fisher Scientific recently completed the $1.85 billion acquisition of PeproTech to increase its capabilities in the high growth cell and gene therapy market.
PeproTech is a privately held...
Pfizer recently entered into a $6.7 billion proposed pharma acquisition deal with Arena Pharmaceuticals to develop therapies for chronic disease management.
Arena Pharmaceutical’s...
Novo Nordisk recently entered into a pharma acquisition deal with Dicerna Pharmaceuticals to increase its pipeline of RNAi therapies and technology platforms.
Dicerna develops RNAi-based...
Merck recently entered into an $11.5 billion pharma acquisition deal with biotechnology company Acceleron Pharma to strengthen its cardiovascular pipeline.
Acceleron focuses on transforming the...
AstraZeneca’s Alexion will fully acquire the remaining equity in Caelum Biosciences for the company’s first-in-class fibril-reactive monoclonal antibody (mAb) to treat rare disease light...
Roche recently signed a definitive share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group to enhance its molecular diagnostic solutions portfolio.
The...
Sanofi recently entered into a $1.9 billion pharma acquisition deal with Kadmon Holdings to strengthen the growth of its transplant business.
Under the terms of the agreement, Sanofi will continue to...
Premier and 11 top health systems recently acquired a minority stake in Exela Holdings, the holding company of Exela Pharma Sciences, to combat drug shortages in the US.
Participating Premier...
Pfizer recently entered into a $2.26-billion pharma acquisition deal with clinical-stage immuno-oncology company, Trillium, to strengthen its next-generation, investigational immuno-therapeutics...
Bayer recently entered into a pharma acquisition deal with Vividion Therapeutics to unlock high value, traditionally undruggable targets with precision therapeutics.
Vividion will leverage its...
Sanofi and Translate Bio recently entered into a $3.2 billion pharma acquisition deal to accelerate the development of mRNA vaccines and therapeutics.
Under the terms of the acquisition,...
Amgen recently entered into a pharmaceutical acquisition deal with Teneobio to discover and develop new biologics to treat various diseases across Amgen’s therapeutic areas.
Teneobio is a...
BioNTech recently entered into an agreement with Kite, a Gilead subsidiary, to acquire its solid tumor neoantigen T cell receptor (TCR) R&D platform and clinical manufacturing facility to...
Eli Lilly and Company recently entered into a pharma acquisition deal with biotechnology company, Protomer Technologies, to advance treatment for type 1 diabetes (TD1).
Protomer...
Gene therapy company uniQure recently entered into a pharma acquisition deal with Corlieve Therapeutics to lead its program for temporal lobe epilepsy.
The program, known as AMT-260, leverages...
Bayer recently entered into a pharma acquisition deal with Noria Therapeutics and PSMA Therapeutics to expand its prostate cancer therapies pipeline.
As part of the acquisition, Bayer will gain...
